HSA — authorised 5 September 2014
- Marketing authorisation holder: KERYX BIOPHARMS
- Status: likely_approved
HSA authorised Auryxia on 5 September 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 5 September 2014.
KERYX BIOPHARMS holds the Singaporean marketing authorisation.